Clinical Trials on Cutaneous Neurofibroma in United Kingdom
Total 944 results
-
Spectrum Health HospitalsVan Andel Research InstituteRecruitingNeurofibromatosis Type 1 | Plexiform Neurofibromas | Cutaneous NeurofibromasUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...AstraZenecaCompletedNeurofibromatosis Type 1 | Optic Nerve Glioma | Plexiform NeurofibromaUnited Kingdom
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis 1 | Plexiform Neurofibroma (PN)United States, Canada, France, Italy, Germany, China, United Kingdom, Spain, Japan, Russian Federation, Australia, Poland, Brazil
-
Nicholas GulatiCompleted
-
Children's National Research InstituteActive, not recruitingNeurofibromatosis 1 | Neurofibroma | Plexiform Neurofibroma | Atypical Neurofibroma | Atypical Neurofibromatosis | Von Recklinghausen DiseaseUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingCutaneous Neurofibroma | NF1 | MonotherapyUnited States
-
University of PittsburghNational Cancer Institute (NCI)Completed
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Neoplasm of Uncertain Malignant PotentialUnited States
-
National Cancer Institute (NCI)TerminatedNeurofibromatosis Type 1 | Plexiform Neurofibroma | Spinal Cord NeurofibromaUnited States
-
Massachusetts General HospitalJohns Hopkins UniversityNot yet recruitingNeurofibromatosis 1 | Neurofibromas, CutaneousUnited States
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
Massachusetts General HospitalJohns Hopkins UniversityActive, not recruitingCutaneous NeurofibromaUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 (NF1) | Plexiform Neurofibromas (PN)United States
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
AstraZenecaApproved for marketingNF type1 With Inoperable Plexiform NeurofibromasUnited States
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharmaActive, not recruitingNeurofibromatosis Type 1 | Plexiform NeurofibromaUnited States
-
Kent RobertsonCompletedNeurofibromatosis | NeurofibromasUnited States
-
Children's Hospital of PhiladelphiaUnited States Department of DefenseTerminated
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
National Cancer Institute (NCI)Completed
-
Indiana UniversityNovartisCompletedNeurofibromatosis | NF1 | NeurofibromasUnited States
-
AlexionRecruiting
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis 1 | Plexiform NeurofibromasUnited States
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibromas | NF1United States
-
Indiana UniversityPfizer; United States Department of DefenseTerminatedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Plexiform NeurofibromasUnited States
-
Children's Hospital of PhiladelphiaCompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Children's Hospital of PhiladelphiaTerminatedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
Drugs for Neglected DiseasesWellcome Trust grant 212346/Z/18/Z - 21st Century Treatments for Sustainable...CompletedVisceral Leishmaniasis | Cutaneous LeishmaniasesUnited Kingdom
-
Shanghai Fosun Pharmaceutical Industrial Development...Active, not recruitingNeurofibromatosis 1 | NF1 | Plexiform NeurofibromaUnited States, China, Spain
-
University of LeedsPfizer; National Institute for Health Research, United Kingdom; Clinical Trials...CompletedLupus Erythematosus, Cutaneous | Lupus Erythematosus, Discoid | Lupus Erythematosus, Chronic CutaneousUnited Kingdom
-
4SC AGCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T Cell LymphomaUnited Kingdom
-
Codiak BioSciencesTerminatedCutaneous T-cell Lymphoma (CTCL)United Kingdom
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Cutaneous Neurofibroma | Optic Nerve GliomaUnited States
-
National Cancer Institute (NCI)Completed
-
University of YorkMedical Research Council; Department for International Development, United...CompletedLeishmaniasis | Cutaneous Leishmaniases | Insect BitesUnited Kingdom
-
Indiana UniversityCompleted
-
Indiana UniversityWithdrawnNeurofibroma, PlexiformUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Neurofibroma, PlexiformUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibroma | Neurofibromatosis Type 1 | Malignant Peripheral Nerve Sheath Tumor | Optic Glioma | Plexiform NeurofibromaUnited States
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Poland, Russian Federation
-
National Cancer Institute (NCI)CompletedNeurofibroma, Plexiform | Neurofibromatosis Type IUnited States, Germany